{"name":"Matinas Biopharma, Inc","slug":"matinas-biopharma-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxOZGNicEtaZlJxeEtrZG05eUpTZXI2QmprS0htaWZWME9FcmhvZnR0VEJsSDNwa0VmeGhONjlOZ2hoaGxlcHBPaWNSZDBIbkREYzZibGFReHlPOTA2Nmw0M3NuUGd5aFVVUndwemhveWxoZTNUMHduY25aYXIwSTVjUWZMTVlNNFo1WVAxZzRsMTN6RjhqeHF6c0VRbkt5TFFZejJoNGRPTjhfSjkwX3RfNzlyd05uVEFE?oc=5","date":"2026-04-03","type":"pipeline","source":"Stock Titan","summary":"Matinas BioPharma has until May 2 to answer NYSE notice - Stock Titan","headline":"Matinas BioPharma has until May 2 to answer NYSE notice","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxOY0dzVkprdlhEQnplRVFxTVJfZk9fTl9oOVcybjd3NWJXcWVJM1Frc3JvSGhLOTFyMUtOaHJZV0lNSTlmYmdDazNlOFJxcWppaVZCOHQ0MmF2MDdvekFFdkNNTEYxM3M0NzdCVW10dWEtSkRiYUlFZHBjVHRJOEgwNWZLNHFxalF2VnNia241b01odHYwaGEySnQ0aUlwdlJfdmhnZWRCRERzY3pMM3R3cGkzb1JraFUxT3RqSA?oc=5","date":"2026-04-03","type":"pipeline","source":"Stock Titan","summary":"Matinas BioPharma (NYSE American: MTNB) faces NYSE non-compliance and cure deadline - Stock Titan","headline":"Matinas BioPharma (NYSE American: MTNB) faces NYSE non-compliance and cure deadline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxOR1hxdTlDMHhuQkd2TzhYaEhkZk8tdFhhT19UVjJmWmxCWV85RElmR1RXUW9ZTEJ1TzQ5YXVjMFRDaXk0M2h6RzNKeV9ZTElxek5WYjFNRWEtTEdJUkVzQmpMRFVRamd3SHVRTnhVTWhuWUtHdElja2g0Mk5tSFJkMFktM3lVcVQ2OFZYVlg3NWwxSWRJMXdaMVFKakkyVjdIal9BSEpIUnZlSFFUeF9mMzBZZFRqRGts?oc=5","date":"2026-03-04","type":"pipeline","source":"Benzinga","summary":"12 Health Care Stocks Moving In Wednesday's Pre-Market Session - 20/20 Biolabs (NASDAQ:AIDX), Can Fite Bi - Benzinga","headline":"12 Health Care Stocks Moving In Wednesday's Pre-Market Session - 20/20 Biolabs (NASDAQ:AIDX), Can Fite Bi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAJBVV95cUxQVWQxTDdWUnBzTFRkS0t4WDhMd08yQnpMekljN3ZqTnl3QjJwRU9nd05JY0lpRzZNMlNSa3Z3OGVLeFd2OVZIOFFaSm1sWUdWYXdaVTl4QVpDMG1lTFp5ajVuclFuU3JzNjdwUlNaeFFxSm9GSTVmcTdYaWZQS251akZEeGVUNmV6QVdvWm9JSThrdm5Id1JlblRRMUxPZTdDWVVuSXJId1p1a3ZhNlpwU0xCbEtIa2FhVHY4VDN0VEIwaUhab2otOUJ6RldaajNFTHZLZEtqTVNjNTRobDVkdm1DNklLbmhYbUZ0SDIyT1FtaTFyYlgwRUtXeVR0ZjhDLUptMEZpVV9DWE4ySFhtVWlDMDA4TF9LbHpvVmhjbWw3TkVl?oc=5","date":"2026-02-09","type":"pipeline","source":"PR Newswire UK","summary":"Invasive Fungal Infections Market to Witness Upsurge in Growth at a CAGR of 11.4% (in the US) During the Forecast Period (2025-2034) | DelveInsight - PR Newswire UK","headline":"Invasive Fungal Infections Market to Witness Upsurge in Growth at a CAGR of 11.4% (in the US) During the Forecast Period","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQT2w1LXhrbHZBYll6WVRBVFE5bHdwNG1UbnBFZWtmT2RtRG5NM20wTUlSRXBXNVNWRVlObEh5bzR5YmU2d2lfaXNDc05RZ0RldVYzOUFpYW5ZcGY5RVJlMV9lY3ZCY1daaEdfcFIwc3dvSjRQWmtybEh5d2NWSUlWYXZUSVRUdjhRcldaSVdKZ0JUZHY5WmY5ZkdZUG00QnBUVTJPalc5Zkh6OGRLT0ZLZ2k1emR5cXR0MzEySDVNMHJ0X1o4SVI2NVFZSlplY3RSMWpaUjRmUEM?oc=5","date":"2026-01-24","type":"pipeline","source":"The Globe and Mail","summary":"Matinas BioPharma CEO Named Interim Chief Financial Officer - The Globe and Mail","headline":"Matinas BioPharma CEO Named Interim Chief Financial Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugJBVV95cUxOQWdoZmprSkg5MDNYVmQ0UWxPTVNrbDAtcnppMjkyRjkzZi1nV3EyMlZqemlGVXBmSTdhMEFDaEdRb1ZVZEtkNnJhUVhSbVRFdUVaUE80R3piWGpiV0p2Q2V2dWo1QktBbnV2aElJZ1NGeUE0bXRtR29xLWFlWkhxVkNybHpwa3dxQUYxYTRjZ3E3NXRTMDN6WXFQdERISUs1S0Y2N3ZmMm1xQXdKOU5Ub3Y4ZTk3UmVIY1FxOENUZmlaWTIyUnYxSWhWajVOMzBtWU9VZXJCSkh4Q0hnUmJ4dmNYaUxZWERoZldleU54TW5MOG5pNkctaGZER3F2eDhiX055OUFOR0tXa3l6T0lQS1c5NVZ5QjJfbHB3cFJYYmVvaXhjcC05LWUtUFMzbTl5RDdlbVZ3Tkd3dw?oc=5","date":"2025-02-13","type":"pipeline","source":"GlobeNewswire","summary":"Matinas BioPharma Announces Agreement for the Acquisition - GlobeNewswire","headline":"Matinas BioPharma Announces Agreement for the Acquisition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAJBVV95cUxPWEZyd1hOQzFxWFdET2NWN3NmaVRsZ09nVXI2R3ZDdTFfQUwwWGlZVXR1NlhncjMzRTBBYWpiejI1bHZHN1pTeTZoVi1uMkZyRVJZcUUtdXpGT3h3b3R2UmN6R1dBSFdRYnBLcjJmUl9kc2JYSkFfOG85cE5HeDFMNkVEenJDSF9HQXA5QTViSkkzLWUzRy1VVzVsdktoVlREOVRta3Y5VTZ1OThhMmhNQ2ExRVBlZUxTTnpOenVsdUNEUzhaUFZJMkxJel96VHVET3Nzamx0aUlTODdTa1luM2lpejVCOHIyLWNhOVE0amVsOXJILVUtbzU0bVNMUmJ6cFhVOXczal9ZTzlSWG5WQkV2a0JKbW1BbjdJZEoyemY?oc=5","date":"2025-01-22","type":"trial","source":"PR Newswire","summary":"Tuberculosis Clinical Trial Pipeline Appears Robust With 30+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - PR Newswire","headline":"Tuberculosis Clinical Trial Pipeline Appears Robust With 30+ Key Pharma Companies Actively Working in the Therapeutics S","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxOOER6RVdLRUdDVTRlNUVHeV9uc0NudFFqWDhNRnBpUDcwMmF4UWo0R0xRMXJtUFZtQmtQVVBrYlFtdU1lM0E2VmFnUmNaVkUzcEpWaGFFbTg2MHg5ZW5iX29ndEg3RGF0bkQ4b25QdGFYNjVVMi1STjA2c2pvVkh2QUtWVU5MV0htOGhic0NDcm1PaVBwclBiME4teWpSYWVLVTlPMG04eFhoUnA1UkNLcVNmdmFGZ25RZktYS2tSNA?oc=5","date":"2024-10-31","type":"deal","source":"Pharmaceutical Technology","summary":"Matinas BioPharma mulls wind-down as antifungal therapy deal falls through - Pharmaceutical Technology","headline":"Matinas BioPharma mulls wind-down as antifungal therapy deal falls through","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxOVnp1VS0zMk02TjRDWG91dUxmY3ZzQmhOd1ZmT0tZR3N4ZHV1cWJIWHhSTHkzV0Y5VmVhWjI0YjV0TmsyQUVCV25sS0JKaFFTZ3Q0dVlfOENJdlpYVGU4ZEl5WnlfMlJPazZnSHRUMjA2SGhhZGFfVTZaemdtanJHSDYyNHZMVVZnckdsODhpdGNBS1ZMNU5Ra21OR29GU09lMzRwbE1nbzJ1dnpwVUx0Z1pFSVlaQQ?oc=5","date":"2022-04-12","type":"deal","source":"Fierce Pharma","summary":"BioNTech sets sights on oral mRNA vaccines with deal to access Matinas delivery technology - Fierce Pharma","headline":"BioNTech sets sights on oral mRNA vaccines with deal to access Matinas delivery technology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxNMUF1MGlGTWFoSmNXRFZjUUEtQkFmZVhxY244VnBxZWNSTzhaNGxoZkxKN1MxekQwLVl3SnA0dVNhNTBVeXlYZzNvSm9JUk5uOUpaTGtlRkRBMkpsLWdObV91bzZMNHk4VzAwRk9iN3d1TXNfM2dzNjRuakhCd2xUV0MzUQ?oc=5","date":"2022-03-29","type":"pipeline","source":"drugdiscoverytrends.com","summary":"Pharma50: 50 of 2021’s Best-Selling Pharmaceuticals - drugdiscoverytrends.com","headline":"Pharma50: 50 of 2021’s Best-Selling Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxNSGNRSXgzMExYZDVqNHJOZ3VDNl8ybGdaaEYxa0xTd3Z2WFhoTHpMTlhHcEhaYTItRUZwcjM3TldGbnFGcEk0VUxubk5SRFRNM2stLVRTYlpOQy1IVllCSG1zX2FLQmNXN3c3ZXhSS2JLamJhamYyNXByY3hKdk5hSWotX0I1b0lCR2JkcnBPWDZQd2J6MUx1Y2V6RXdKdGJJdXlHYlJudnRWRnpWbVNmcU1Jc3c2X2ZQYlVxM1VVVzJieUU0YzJ5SmVWZlRFNG9rSF9VVVJZRjdoN3dyLWM5M0thVFhyZVAzYWRlMlRUa0dMUQ?oc=5","date":"2020-03-31","type":"pipeline","source":"Proactive financial news","summary":"Matinas BioPharma weighs in on Amarin drug case, pauses clinical enrollment amid coronavirus - Proactive financial news","headline":"Matinas BioPharma weighs in on Amarin drug case, pauses clinical enrollment amid coronavirus","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNNFpORml3WW5CQ2lwLTV1TmgweXVsbS1TcG81ak8xM1psaEx6WEFSUWR3ZzRMWkJib1hkc2N3OUhnYkc5bDc5MWxFdWRTamNBTjZfVmhTRTJzdENLUXJJWHg4U2k4MU9jVVlCaWk0RlZpMGRzNTl0OXRuZU5jSndEYXI2OFJ0Nlg4bjAtRFNxWXNCcjdrUk9ZbEdJVE1yUzlpZ2FpR3NIYUhtN3Bo?oc=5","date":"2018-03-19","type":"pipeline","source":"New Jersey Business Magazine","summary":"Matinas BioPharma Appoints Jerome D. Jabbour as Chief Executive Officer - New Jersey Business Magazine","headline":"Matinas BioPharma Appoints Jerome D. Jabbour as Chief Executive Officer","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}